Marek Kubicki1, Martha E Shenton. 1. aPsychiatry Neuroimaging Laboratory, Departments of Psychiatry and Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston bVeterans Affairs (VA) Boston Healthcare System, Brockton, Massachusetts, USA.
Abstract
PURPOSE OF REVIEW: Schizophrenia is a multifocal brain disease that involves abnormal brain connectivity. Diffusion Tensor Imaging is the most advanced imaging technique to investigate white matter connections in vivo. In this review, we focus on studies published in the last year with a high impact on our understanding of how changes in white matter may lead to better treatment. RECENT FINDINGS: Recent studies establish white matter changes at illness onset, and quite possibly before, wherein they constitute a risk factor. Some studies also suggest that white matter changes might not progress over time, even without treatment. Further, while genetic risk may be associated with neurodevelopmental changes related to either white matter geometry, or a different trajectory of aging, clinical risk may also be associated with more acute changes of tissue integrity. These latter changes may be inflammatory in nature at illness onset, and related to the cellular integrity of oligodendrocytes and/or astrocytes at later stages of illness. SUMMARY: Recent publications suggest new directions for research and lead to new hypotheses about the pathophysiology of schizophrenia involving white matter. When replicated on larger samples, this knowledge will likely lead to the development of new treatment strategies.
PURPOSE OF REVIEW: Schizophrenia is a multifocal brain disease that involves abnormal brain connectivity. Diffusion Tensor Imaging is the most advanced imaging technique to investigate white matter connections in vivo. In this review, we focus on studies published in the last year with a high impact on our understanding of how changes in white matter may lead to better treatment. RECENT FINDINGS: Recent studies establish white matter changes at illness onset, and quite possibly before, wherein they constitute a risk factor. Some studies also suggest that white matter changes might not progress over time, even without treatment. Further, while genetic risk may be associated with neurodevelopmental changes related to either white matter geometry, or a different trajectory of aging, clinical risk may also be associated with more acute changes of tissue integrity. These latter changes may be inflammatory in nature at illness onset, and related to the cellular integrity of oligodendrocytes and/or astrocytes at later stages of illness. SUMMARY: Recent publications suggest new directions for research and lead to new hypotheses about the pathophysiology of schizophrenia involving white matter. When replicated on larger samples, this knowledge will likely lead to the development of new treatment strategies.
Authors: Peter D Alexander; Kristina M Gicas; Alex Cheng; Donna J Lang; Ric M Procyshyn; Alexandra T Vertinsky; William J Panenka; Allen E Thornton; Alexander Rauscher; Jamie Y X Wong; Tasha Chan; Andrea A Jones; F Vila-Rodriguez; William G Honer; Alasdair M Barr Journal: Psychopharmacology (Berl) Date: 2019-06-22 Impact factor: 4.530
Authors: Kurt Schilling; Yurui Gao; Iwona Stepniewska; Ann S Choe; Bennett A Landman; Adam W Anderson Journal: Magn Reson Imaging Date: 2016-08-29 Impact factor: 2.546
Authors: Daniel Bergé; Anna Mané; Tyler A Lesh; Miquel Bioque; Fe Barcones; Ana Maria Gonzalez-Pinto; Mara Parellada; Eduard Vieta; Josefina Castro-Fornieles; Roberto Rodriguez-Jimenez; Maria Paz García-Portilla; Judith Usall; Cameron S Carter; Bibiana Cabrera; Miguel Bernardo; Joost Janssen Journal: Schizophr Bull Date: 2020-07-08 Impact factor: 9.306
Authors: Hesham M Hamoda; A T Makhlouf; J Fitzsimmons; Y Rathi; N Makris; R I Mesholam-Gately; J D Wojcik; J Goldstein; R W McCarley; L J Seidman; M Kubicki; M E Shenton Journal: Brain Imaging Behav Date: 2019-04 Impact factor: 3.978
Authors: L E Laskaris; M A Di Biase; I Everall; G Chana; A Christopoulos; E Skafidas; V L Cropley; C Pantelis Journal: Br J Pharmacol Date: 2016-01-08 Impact factor: 8.739
Authors: Matcheri S Keshavan; Guusje Collin; Synthia Guimond; Sinead Kelly; Konasale M Prasad; Paulo Lizano Journal: Neuroimaging Clin N Am Date: 2019-11-11 Impact factor: 2.264
Authors: Natalia Tesli; Lars T Westlye; Guttorm B Storvestre; Tiril P Gurholt; Ingrid Agartz; Ingrid Melle; Ole A Andreassen; Unn K Haukvik Journal: Eur Arch Psychiatry Clin Neurosci Date: 2019-01-29 Impact factor: 5.270